You are here

Article info

Article menu
Coronary artery disease
Original research
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

Authors

  • Dimitrios Venetsanos Division of Cardiology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Karolinska Institutet Solna, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Erik Träff Department of Cardiology and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Sciences, Linköping University Linköping, Linkopings Universitet, Linkoping, Sweden PubMed articlesGoogle scholar articles
  • David Erlinge Department of Cardiology, Lund University, Lund, Sweden PubMed articlesGoogle scholar articles
  • Emil Hagström Department of Medical Sciences, Uppsala University, Uppsala Universitet, Uppsala, SwedenDepartment of Medical Sciences, Cardiology, Uppsala Universitet, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Johan Nilsson Department of Cardiology, Umeå University, Umea Universitet, Umea, Sweden PubMed articlesGoogle scholar articles
  • Liyew Desta Division of Cardiology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Karolinska Institutet Solna, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Bertil Lindahl Department of Medical Sciences, Uppsala University, Uppsala Universitet, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Linda Mellbin Division of Cardiology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Karolinska Institutet Solna, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Elmir Omerovic Department of Cardiology, Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden, Sahlgrenska Academy, Goteborg, Sweden PubMed articlesGoogle scholar articles
  • Karolina Elisabeth Szummer Division of Cardiology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Karolinska Institutet Huddinge, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Sammy Zwackman Department of Cardiology and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Sciences, Linköping University Linköping, Linkopings Universitet, Linkoping, Sweden PubMed articlesGoogle scholar articles
  • Tomas Jernberg Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institute, Stockholm, Sweden PubMed articlesGoogle scholar articles
  • Joakim Alfredsson Department of Cardiology and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Sciences, Linköping University Linköping, Linkopings Universitet, Linkoping, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dimitrios Venetsanos, Division of Cardiology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Karolinska Institutet Solna, Stockholm, Sweden; dimitrios.venetsanos{at}liu.se
View Full Text

Citation

Venetsanos D, Träff E, Erlinge D, et al
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention
Heart 2021;107:1145-1151.

Publication history

  • Received November 20, 2020
  • Revised February 18, 2021
  • Accepted February 20, 2021
  • First published March 12, 2021.
Online issue publication 
June 30, 2021

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.